Morgan Stanley toned down its emphasis on diversity in its latest annual report published on Friday, signaling a recalibration as businesses adapt to a changing reality under President Donald Trump's ...

US defense contractors are on shaky ground just a month into the new administration — taking a backseat to European peers — as mounting concerns over a deluge of policies including a tightened ...

The general mood among these heavyweight investors is divided, with 57% leaning bullish and 21% bearish. Among these notable ...

The most talked about and market moving research calls around Wall Street are now in one place. Here are today’s research calls that investors need to know, as compiled by The Fly. Top 5 Upgrades: ...

Four leading City banks were today fined more than £100 million for unlawfully sharing market sensitive information about the ...

RBC Capital analyst Charles Weston maintained a Buy rating on Sartorius Stedim Biotech (0RG8 – Research Report) today and set a price target of ...

Barclays hit the dollar market in force with two trades in successive days this week to raise a total of $6.5bn.

Non-profit healthcare provider HCA Inc printed the biggest trade of the week as it raised $5.25bn in a six-part offering to repay its borrowing facility. Wells Fargo, Barclays, Bank of America, Citi, ...

Stocks were mostly lower on Thursday after a disappointing business forecast from retail giant Walmart (WMT). The S&P 500, ...

Discover key insights from TFI International's Q4 2024 earnings, including market challenges, operational improvements, and strategic moves like U.S.

In terms of liquidity and interest, the mean open interest for CRISPR Therapeutics options trades today is 628.14 with a total volume of 1,152.00.

RBC Capital analyst Matt McKellar reiterated a Hold rating on James Hardie (JHIUF – Research Report) yesterday and set a price target of ...